What it is
Ariessence PDGF+ is a growth-factor therapy built around recombinant human platelet-derived growth factor. PDGF is one of the body’s own signaling molecules for tissue repair and collagen synthesis. Delivered to the skin via microinjection or through microneedling channels, it supports the same regenerative cascade that platelet-rich plasma triggers — but with a standardized, repeatable concentration per session rather than the patient-to-patient variability of autologous PRP.
How we approach it
We use Ariessence most often paired with microneedling, in a series of three sessions spaced four to six weeks apart. The clinician selects depth and concentration per skin type.
For patients who prefer an autologous (own-body) approach, traditional PRP remains the alternative. For patients who want a standardized growth-factor concentration without the blood draw, Ariessence is the call.
What to expect
A comfortable session with mild post-treatment pinkness for one to two days. Visible texture and tone change at four to eight weeks. Cumulative across the series.
Candidacy
Best for patients seeking skin quality improvement with a standardized regenerative protocol. Not for active infection in the treatment area, pregnancy, or active cancer without oncology clearance.